Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

Citeline Podcasts
Claim This Podcastby Norstella
Podcast Authority
Beta
Podcast Overview
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
Language
🇺🇲
Publishing Since
8/26/2021
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
2 verified contact emails on file for Citeline Podcasts
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

June 9, 2026
플랙쉽 파이오니어링, 한국서 장기적 파트너십, 바이오 생태계 성장 모색 (Korean-language podcast)
Flagship Pioneering's Chairman of Asia Pacific Andre Andonian and Special Advisor for Korea Byungkun Lee discuss their Korean market entry strategy, exploring long-term partnerships and applying their venture creation model to the local biopharma ecosystem in this interview.

June 8, 2026
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) June 8, 2026
Citeline Podcasts host [Host Name] interviews industry experts on key biopharmaceutical business developments, including Revolution's daraxonrasib success and Merck's oncology strategy.

June 8, 2026
Scrip's Five Must-Know Things - June 8, 2026
Citeline Podcasts' "Scrip's Five Must-Know Things" delivers a biopharma industry audio roundup covering Revolution's daraxonrasib, Merck's oncology vision, US-China deal scrutiny, obesity drug news, and pharma CEO pay trends.
1,063 total episodes available with 512 transcripts
Recent guests on Citeline Podcasts
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Derrick Gingery
Guest
Maaisha Osman
Guest
Sue Sutter
Guest
Nielsen Hobbs
Guest
David Wallace
Guest
Britt Meelby Jensen
Guest
Yerem Yeghiazarians
Guest
Carrie Melvin
Guest
Rob Reid
Guest
Ross Pettit
Guest
Scott Davis
Guest
Mike McCaughan
Guest
Similar Podcasts
Discover related shows you might enjoy

The Readout Loud
STAT

BioCentury This Week
BioCentury

Biotech Hangout
Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

The Long Run with Luke Timmerman
Timmerman Report

a16z Podcast
Andreessen Horowitz

Bloomberg Daybreak: US Edition
Bloomberg

Coaching Real Leaders
Harvard Business Review / Muriel Wilkins

HBR IdeaCast
Harvard Business Review

WSJ Your Money Briefing
The Wall Street Journal

Hard Fork
The New York Times

WSJ's Take On the Week
The Wall Street Journal

WSJ Tech News Briefing
The Wall Street Journal

NEJM AI Grand Rounds
NEJM Group

The Art of Manliness
The Art of Manliness

The Prof G Pod with Scott Galloway
Vox Media Podcast Network
Deep-dive analytics for Citeline Podcasts
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Citeline Podcasts?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.